Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000228289 is annotated as a **pseudogene**, defined as a DNA sequence with high homology to a functional gene but unable to code for a functional protein product[1][2]. Most pseudogenes do not have a direct biological function, though some are transcribed into RNA and may participate in regulatory networks through RNA interference mechanisms or as miRNA sponges[3][4]. There are no known therapeutic, pharmacologic, or classical molecular target roles for this entity—pseudogenes are typically not directly targeted in drug development. This specific pseudogene appears to be annotated based on sequence similarity to a gene in the mouse genome but lacks evidence of protein-coding capacity or therapeutic relevance. In summary, **ENSG00000228289** is not a protein, enzyme, receptor, or classical molecular target suitable for therapeutic intervention, and there is nothing to suggest it functions as one. Its only established role is as a **pseudogene**, possibly transcribed as non-coding RNA without evidence of direct clinical utility[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to the likely ortholog of mouse gene rich cluster, C10 (ENSG00000228289).